A tale of three labels: translating the JUPITER trial data into regulatory claims.

BACKGROUND Whether a pivotal randomized trial will be interpreted in a similar and consistent manner by different regulatory agencies is uncertain as policy perspectives may play a role in data interpretation and the translation of trial results into clinical practice. PURPOSE Using a contemporary example, to compare and contrast regulatory claims in the… CONTINUE READING